Sickle Cell Disease (SCD)is an inherited red blood cell disorder. Thisgenetic disorder results from the presence of mutated form of hemoglobin, called hemoglobin S (HbS) or sickle hemoglobin in the red blood cells. People with sickle cell disease have atypical hemoglobin molecules which can distort red blood cells into a sickle or crescent shape. It is caused by the mutation in the genes that make hemoglobin. The most common and severe kind of SCD is the Sickle Cell Anemia. Other forms include sickle-hemoglobin C disease, sickle β0 thalassemia and sickle β+ thalassemia.

1. Sickle Cell Disease
Market Insights, Epidemiology, and
Market Forecast-2025
DelveInsight © 2017 | All rights reserved

2. SICKLE CELL DISEASE (SCD)
• Sickle Cell Disease (SCD)is an inherited red blood cell disorder. Thisgenetic
disorder results from the presence of mutated form of hemoglobin, called
hemoglobin S (HbS) or sickle hemoglobin in the red blood cells.
• People with sickle cell disease have atypical hemoglobin molecules which can
distort red blood cells into a sickle or crescent shape. It is caused by the mutation in
the genes that make hemoglobin.
• The most common and severe kind of SCD is the Sickle Cell Anemia. Other forms
include sickle-hemoglobin C disease, sickle β0 thalassemia and sickle β+
thalassemia.
DelveInsight © 2017 | All rights reserved

3. MAIN
GOALS
SCOPE OF REPORT
To understand the future
market competition in the
global Sickle Cell Disease
market and Insightful review
of the key market drivers and
barriers.
Report covers the disease
overview including etiology,
path physiology, symptoms,
diagnosis, disease management,
and current treatment options.
To understand the regulatory scenario in 7 major
markets i.e. United States, Europe (Germany, Spain,
Italy, France and United Kingdom) and Japan
Report covers the detailed
global historical and
forecasted Sickle Cell
Disease Epidemiology
covering 7Major Markets
from 2015-2025.
The report will help in
developing business
strategies by understanding
the trends shaping and
driving the global Sickle Cell
Disease scenario.
DelveInsight © 2017 | All rights reserved

4. MARKET FINDINGS
The report is built using
data and information
sourced from proprietary
databases, primary and
secondary research and in-
house Forecast model
analysis by Publisher team
of industry experts.
Sickle Cell Disease occurs in
approximately 300,000 births
annually. It is mostly
prevalent areas, primarily
Africa, the Middle East and
South Asia.
In many African countries, 10
to 40% of population carries
the sickle cell gene, resulting in
estimated SCD prevalence of at
least 2%.
DelveInsight © 2017 | All rights reserved

5. MARKET OVERVIEW
42%
13%11%
10%
5%
5%
14%
Global Market Size of Sickle Cell Disease in 2016
US Germany France UK Spain Italy Japan
DelveInsight © 2017 | All rights reserved

6. EPIDEMIOLOGY FORECAST
OVERVIEW
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
PatientPopulationinNumbers(N)
Prevalent Cases of Sickle Cell Disease (SCD) -7MM
US Germany France Italy Spain UK Japan
DelveInsight © 2017 | All rights reserved

7. MARKET ANALYSIS
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
SalesinUSD,Million
7 MM- Market Size (2015-2025)
DelveInsight © 2017 | All rights reserved

8. Complete Information
For complete information please click below
Or
Write to us at
info@delveinsight.com
CLICK HERE
DelveInsight © 2017 | All rights reserved

9. About DelveInsight
DelveInsight, market research and consulting firm, provides end to
end comprehensive solutions to the Life Science Industry.
We help our customers in best decision making through our
expertise in research & analysis and comes out with unmatched data
& forecasts
Vision
“Insight across the value chain”
to help organizations make
important business decisions
through the use and analysis of actionable
market intelligence
Mission
To be the most trusted marketing research
firm & business consulting firm worldwide.
To be a renowned and premier data driven
solution providers among Pharma & Biotech
companies.
DelveInsight © 2017 | All rights reserved

10. • Trends Analysis
• Physicians & Patients Perception
• KOLs
• Market Size
• Market Dynamics
• Market Assessment
Service Offerings at DelveInsight
Comprehensive solution for strategic business decisions
Access over 3000+ Reports
• API
• Market & Pipeline
• Indication & Epidemiology
• Drug Sales Forecast
• Indication Forecast
• Late Stage Pipeline Analysis
• Asset Prioritization
• Brand Optimization
• Portfolio Expansion
Opportunity Assessment for
• Licensing
• Market Access
• Partnership
• Competitive landscape
• Clinical Trials
• Therapeutic Assessment
• Primary Analytics
• News-Letters
• Conference Tracking
• Clinical Trials Tracking
Market
Intelligence
Consulting
SociAlytics
Pipeline
Forecasting
DelveInsight © 2017 | All rights reserved

11. Add a Slide Title - 5
Contact Us:
info@delveinsight.com
+91-11-4568 9769
www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight